According to WHO, dengue affects about 50-100 million people worldwide, annually. It is a vector-borne highly communicable disease. This report discusses the diagnostic tests used to confirm the presence of dengue in one individual.
The growth of the global dengue virus diagnostic tests market is driven by an increase in the incidence of dengue fever. However, low awareness in emerging nations and high under diagnosis rate restrain the market growth at present. Rising awareness about symptoms for dengue fever and increasing government initiatives to provide better healthcare facilities will provide ample opportunities for the market growth.
The dengue virus diagnostic tests market is segmented based on type, end user, and region. By type, the market is segmented into rapid molecular assay, biomarker assay, IsoAmp assay, and others. Based on end user, it is segmented into hospitals, research institutes, and others.
Geographically, it has been analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
The key players that operate in the market include Arkray Inc., Ceres Nanosciences Inc., Roche Diagnostics International, Corgenix Medical Corp, FK-Biotecnologia SA, QuantuMDx Group Ltd., Sansure Biotech Inc., Quidel Corp, Whidiag SAS, and Pictor Ltd.
- The study provides an in-depth analysis of the market with current trends and future estimations to elucidate imminent investment pockets.
- Comprehensive analysis of all geographical regions has been provided to determine prevailing opportunities.
- Key players are profiled and their strategies thoroughly analyzed, which explains the competitive outlook of the global market.
- The report offers a quantitative analysis from 2016 to 2023 to enable stakeholders to capitalize on prevailing market opportunities.
Dengue Virus Diagnostic Tests Market Key Segments:
- Rapid Molecular Assay
- Biomarker Assay
- IsoAmp Assay
By End User
- Research Institutes
"Note : The list of companies mentioned in the description is tentative in nature and may change after detailed analysis."
- North America
- Rest of Europe
- South Korea
- Rest of Asia-Pacific
- Saudi Arabia
- South Africa
- Rest of LAMEA